Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Forensic Toxicology|August 23, 2016
Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytesXingxing Diao, Karl B Scheidweiler, Ariane Wohlfarth, et al.
Drug Testing and Analysis|March 27, 2018
Metabolism study for CUMYL-4CN-BINACA in human hepatocytes and authentic urine specimens: Free cyanide is formed during the main metabolic pathwayAnna Åstrand, Svante Vikingsson, Daniel Lindstedt, et al.
Bioanalysis|July 22, 2014
Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MSAdarsh S Gandhi, Mingshe Zhu, Shaokun Pang, et al.
Analytical and Bioanalytical Chemistry|February 13, 2014
Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometryAriane Wohlfarth, Adarsh S Gandhi, Shaokun Pang, et al.
Forensic Science International|November 20, 2016
Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometryAriane Wohlfarth, Svante Vikingsson, Markus Roman, et al.
Bioanalysis|June 21, 2014
Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MSAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Forensic Toxicology|January 22, 2016
4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometryKayla N Ellefsen, Ariane Wohlfarth, Madeleine J Swortwood, et al.
Forensic Science International|March 4, 2011
Ethyl sulphate and ethyl glucuronide in vitreous humor as postmortem evidence marker for ethanol consumption prior to deathAnnette Thierauf, Jürgen Kempf, Markus Grosse Perdekamp, et al.
Drug Testing and Analysis|September 3, 2015
Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmationAriane Wohlfarth, Karl B Scheidweiler, Shaokun Pang, et al.
The AAPS Journal|August 7, 2016
Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass SpectrometryMichael G Feasel, Ariane Wohlfarth, John M Nilles, et al.
Pageof 5